Stocks and Investing Stocks and Investing
Wed, January 8, 2014
Tue, January 7, 2014
Mon, January 6, 2014
Sun, January 5, 2014
Fri, January 3, 2014
Thu, January 2, 2014
Tue, December 31, 2013
Fri, December 27, 2013
Tue, December 24, 2013
Mon, December 23, 2013
Fri, December 20, 2013
Thu, December 19, 2013
Wed, December 18, 2013
Tue, December 17, 2013
Mon, December 16, 2013
Fri, December 13, 2013
Thu, December 12, 2013
Wed, December 11, 2013
Tue, December 10, 2013
Mon, December 9, 2013
Fri, December 6, 2013
Thu, December 5, 2013
Wed, December 4, 2013
Tue, December 3, 2013
Mon, December 2, 2013
Fri, November 29, 2013
Wed, November 27, 2013
Tue, November 26, 2013
Mon, November 25, 2013
Fri, November 22, 2013
Thu, November 21, 2013
Wed, November 20, 2013
Tue, November 19, 2013
Mon, November 18, 2013
Fri, November 15, 2013
Thu, November 14, 2013
Wed, November 13, 2013
Tue, November 12, 2013
Mon, November 11, 2013
Fri, November 8, 2013
Thu, November 7, 2013
Wed, November 6, 2013
Tue, November 5, 2013
Mon, November 4, 2013
Fri, November 1, 2013
Thu, October 31, 2013
Wed, October 30, 2013
Tue, October 29, 2013
Mon, October 28, 2013
Fri, October 25, 2013
Thu, October 24, 2013

Christopher Raymond Initiated (BMRN) at Buy on, Nov 26th, 2013




Christopher Raymond of Piper Sandler, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy on, Nov 26th, 2013.

Christopher has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Christopher's Rating of Hold.



This is the rating of the analyst that currently disagrees with Christopher


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $85 on, Thursday, September 5th, 2013

Publication Contributing Sources

Similar Stocks and Investing Publications